Sanjay Gupta's 'Weed 8: Women and Weed' — Why Women Are Now Cannabis's Fastest-Growing Demographic

On April 19, 2026, CNN Chief Medical Correspondent Dr. Sanjay Gupta premiered the eighth installment of his Emmy-nominated Weed documentary series — and this time, the spotlight lands squarely on the women quietly reshaping America's relationship with cannabis.

Weed 8: Women and Weed arrives at a watershed moment. For the first time in recorded history, women have outpaced men as cannabis consumers in the United States. The documentary doesn't just acknowledge that statistical milestone — it dives into the deeply personal stories behind the numbers.

A Documentary That Feels Different

Gupta's Weed series has always been ahead of the cultural curve. His first installment in 2013 is widely credited with shifting mainstream medical opinion on cannabis, particularly around pediatric epilepsy. Each subsequent chapter has tackled a different frontier — veterans, the opioid crisis, international markets.

But Weed 8 marks perhaps the most significant tonal shift in the franchise. Rather than focusing on policy debates or laboratory findings, this installment centers the lived experiences of women who turned to cannabis after exhausting every conventional option available to them.

The documentary profiles grandmothers managing chemotherapy side effects, professional athletes navigating endometriosis pain, and teachers weathering the sleeplessness and mood destabilization of perimenopause — all of whom found relief in cannabis when traditional medicine fell short.

The Numbers Behind the Narrative

The timing of Weed 8 isn't accidental. Recent data confirms that women represent the fastest-growing segment of cannabis consumers in the United States, a trend that's been building for several years but crossed a critical threshold in early 2026.

Several factors converge to explain the shift. First, cannabis products designed specifically for women's health concerns — from menstrual pain to menopausal symptoms — have proliferated in legal markets. These aren't simply repackaged generic products with pink labels; many feature targeted cannabinoid ratios and delivery methods developed through clinical feedback.

Second, the destigmatization of cannabis use among professional women has accelerated dramatically. Where even five years ago, a female executive admitting to cannabis use might face career consequences, today's cultural landscape treats it with roughly the same nonchalance as a glass of wine.

Third, and perhaps most importantly, women's frustration with conventional medicine's track record on conditions like chronic pain, autoimmune disorders, and hormonal imbalances has reached a tipping point. When you've been told your pain is "in your head" by multiple physicians, the willingness to explore alternatives grows exponentially.

The Medical Establishment Responds

One of the documentary's most compelling segments examines how the medical establishment is responding — or failing to respond — to this patient-driven shift. Several major medical organizations have called for a reevaluation of cannabis's Schedule I classification in 2026, citing growing evidence of therapeutic benefit in areas particularly relevant to women's health.

Yet the disconnect between patient experience and institutional caution remains vast. Many gynecologists and primary care physicians still feel uncomfortable discussing cannabis with patients, creating an information vacuum that's often filled by dispensary staff or social media rather than clinical expertise.

Gupta interviews physicians on both sides of this divide — those who've integrated cannabis discussions into their practice and those who remain skeptical. Neither camp comes across as villainous; the documentary captures genuine uncertainty in a medical system built for pharmaceutical certainty.

Women Building the Industry

Beyond consumers and patients, Weed 8 profiles the women building the cannabis industry itself. From cultivators and extraction scientists to brand founders and dispensary owners, women are occupying every link in the supply chain.

These entrepreneurs aren't simply entering an existing industry — they're actively reshaping it. Products designed by women for women tend to prioritize precise dosing, discreet consumption methods, and wellness-forward branding that would have been unthinkable in cannabis culture a decade ago.

The documentary features several founders who explicitly cite their own health struggles as motivation for launching their companies. Unable to find cannabis products that addressed their specific needs, they created them — guided by empathy and experimentation rather than the profit-maximization that drives much of the industry.

The Perimenopause Connection

One of the documentary's most discussed segments focuses on cannabis and perimenopause — the transitional period before menopause that can begin years before a woman's final period. Symptoms including hot flashes, insomnia, anxiety, joint pain, and cognitive fog can significantly impact quality of life, yet treatment options remain limited and controversial.

Gupta reports on emerging research suggesting certain cannabinoid combinations may address multiple perimenopausal symptoms simultaneously — a potential advantage over conventional treatments that typically target symptoms individually. However, he's careful to note that rigorous clinical trials remain scarce, and what works anecdotally doesn't always survive scientific scrutiny.

The segment resonates because it validates what millions of women have discovered independently: cannabis helps them sleep, reduces anxiety, and eases physical discomfort during a life transition that mainstream medicine has historically underserved.

Cultural Impact and Timing

The premiere of Weed 8 on the eve of 4/20 2026 is deliberate positioning. By airing the documentary during America's unofficial cannabis holiday, CNN ensures maximum cultural penetration at exactly the moment when cannabis conversation reaches its annual peak.

But beyond marketing strategy, the timing reflects a deeper truth: 4/20 in 2026 looks nothing like 4/20 in 2016. The holiday has evolved from a countercultural celebration into something closer to a mainstream wellness moment — and women are driving that evolution.

What This Means Going Forward

If Gupta's previous documentaries are any guide, Weed 8 will accelerate trends already in motion. His 2013 documentary didn't create support for medical cannabis, but it gave millions of Americans permission to support it openly. Similarly, Weed 8 won't create the women-and-cannabis movement, but it may give it mainstream cultural legitimacy that accelerates both consumer adoption and medical research.

For the cannabis industry, the implications are clear: the future consumer is increasingly likely to be female, wellness-motivated, and demanding of products that meet her specific needs. Brands and dispensaries that recognize this shift will thrive; those clinging to outdated demographic assumptions will find themselves serving a shrinking market.

The documentary is available for streaming on CNN's platforms following its premiere broadcast. Given the trajectory of Gupta's previous installments, expect Weed 8 to remain a reference point in cannabis discourse for years to come.